Fidelity International’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Fidelity International’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-93,057	Closed	-$10.6M	–	1008
2019 Q1	$10.6M	Sell	93,057 -6,308	-6%	-$464K	0.02%	429
2018 Q4	$3.89M	Buy	99,365 +36,217	+57%	+$1.57M	0.01%	532
2018 Q3	$3.44M	Sell	63,148 -13,069	-17%	-$894K	0.01%	579
2018 Q2	$6.31M	Sell	76,217 -2,917	-4%	-$225K	0.01%	532
2018 Q1	$5.27M	Sell	79,134 -8,084	-9%	-$467K	0.01%	401
2017 Q4	$4.49M	Buy	87,218 +19,953	+30%	+$1.43M	0.01%	419
2017 Q3	$6M	Buy	+67,265	New	+$5.11M	0.02%	385
2015 Q3	–	Sell	-58,768	Closed	-$3.54M	–	550
2015 Q2	$3.54M	Buy	58,768 +7,533	+15%	+$498K	0.01%	443
2015 Q1	$3.97M	Buy	+51,235	New	+$2.95M	0.01%	424

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity International's ONCE Position: Q2 2019 in Review

Fidelity International sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 93,057 shares — an estimated $10.6M sold.

Fidelity International first reported a position in ONCE in Q1 2015 and held it in 9 quarters. The position peaked at $10.6M in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

Fidelity International reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Fidelity International sold 93,057 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $10.6M.
Fidelity International first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Fidelity International's Spark Therapeutics, Inc. Common Stock position peaked at $10.6M in Q1 2019.
194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Fidelity International's 13F filing for Q2 2019, filed 13 Aug 2019.